Effective Timing of Marketing Activities -- Part 2

Parallel process branding & other marketing tasks to move drugs to market quickly with multiple indications. Pharmaceutical manufacturers recognize the importance of balancing speed to market with speed to market penetration. The result of a balanced, successful development process can be a product that has the optimal molecular construction, technical specs, and market demand, with multiple approved indications. The struggle to work with such a balanced, multi-indication product drove one benchmark partner to adopt a strategy of parallel processing tasks at the end of the development process. The company believes that broad labeling is crucial to achieving and maintaining market share, a far more important strategic goal than rapid but short-lived market success. The company maintains a single development team, but members focus on different indications so that there are de facto subteams working on up to 20 different indications at the end of Phase III ...

Industries Profiled:
Pharmaceutical


Companies Profiled:
A Leading Pharmaceutical Company

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.